Options Brief: Orexigen Therapeutics, Inc.

Shares of Orexigen Therapeutics, Inc. OREX are lower on the session by 10.24%, trading at $1.90. Overall put volume is now running at 2.09x the daily average, with 55% of all puts traded being purchases on the offer. 2,105 contracts have traded on the session so far. Orexigen Therapeutics, Inc. is a biopharmaceutical company focused on the development of pharmaceutical product candidates for the treatment of obesity.